Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

Using the microscopic structures found on the wings of the Morpho butterfly, researchers have developed a simple and inexpensive way to analyze cancer biopsy samples that could make cancer diagnosis ...

The firm plans to build on its organ and tissue modeling technology to develop more sophisticated tests, including full-body digital twins.

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...

Empa researchers have developed a new 3D tissue analysis for thyroid tumors. This special X-ray technique uses artificial ...

Breast Cancer Canada wants quality of life feedback from patients to drive research moving forward – so they’re asking patients to share their experience in a new study. Plus, the man van will roll ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

The incorporation of all these biomarkers into routine screening could revolutionise prostate cancer management by enabling ...

OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

At the forefront of advanced and holistic treatments, Mount Elizabeth Hospital uses a comprehensive team approach in treatments.